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ABSTRACT
One of the most common of deficits observed in Fetal Alcohol Spectrum Disorders (FASD) is
difficulties with attention. Because attention deficits are commonly treated with stimulants, the
impact of d-amphetamine (AMPH) treatment during the juvenile period in an animal model of
FASD was examined. A dose-response study first assessed the appropriate dose of AMPH to use.
In the dose-response study, therapeutic doses of 0.5, 1.0, and 2.0 mg/kg/day of AMPH were
chronically administered to female rats between postnatal days (PD) 26-40. Rats were subjected
to an open field test on the first and last day of treatment. The dose of 1.0 mg/kg/day was the
lowest dose which resulted in significant behavioral sensitization and therefore was selected for
the FASD study. In the FASD study, pups were exposed to alcohol between PD 2 and 10. Control
groups included an intubated control (IC) and a non-treated control (NC). At PD 26, rats were
randomly assigned to either amphetamine or water treatment for twice-daily subcutaneous
injections from PD 26 to 41. On PD 26, 27, 40, and 41, an open field test was administered to
assess locomotion. On PD 42, the rats were perfused, and the brains were removed and
prepped for histological measures. The results indicated that amphetamine increased

distance traveled acutely, and that this effect became greater over days of treatment.
Amphetamine-treated rats exhibited significantly more rearing behaviors and less
grooming behavior than water-treated rats. Both rearing and grooming behavior
decreased over test days. There was no effect of alcohol exposure on any open field
measures. Dopaminergic and noradrenergic systems were analyzed via
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immunohistochemistry for tyrosine hydroxylase (TH), the dopamine transporter (DAT)
and dopamine-beta-hydroxylase (DBH). An omnibus ANOVA revealed no impact of
alcohol exposure or amphetamine treatment on TH or DAT within the nucleus
accumbens core. Although amphetamine treatment caused a small but significant
increase in DBH within the medial prefrontal cortex, there was no effect of alcohol
exposure on this measure. These results suggest that catecholaminergic neurons are
resistant to the developmental impact of alcohol. However, juvenile amphetamine
treatment may increase noradrenergic synthesis or innervation within the prefrontal
cortex, influencing developmental trajectories.
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CHAPTER 1
INTRODUCTION
1.1 ALCOHOL IS A TERATOGEN
An alcohol is any compound containing a functional hydroxyl group attached to a
saturated hydrocarbon (Pohorecky & Brick, 1990). Although there are multiple types of
alcohols, humans typically consume ethyl alcohol, an amphipathic molecule with a
negatively charged oxygen “head” and a neutral methyl “tail” (Pohorecky & Brick, 1990).
This amphipathic property allows its distribution throughout bodily tissues, including
easy passage through the blood brain barrier where it can affect functioning of neural
systems (Hanig et al., 1972). The result is a state of intoxication. At low doses, alcohol
intoxication is associated with decreased inhibitions, elevated mood, and impaired
motor coordination (Davidson et al., 1997). At high levels, intoxication is associated with
stupor, coma, and potentially death (Sanap & Chapman, 2003). Despite these risks,
alcohol use transcends cultures. It is the oldest psychoactive compound consumed by
humans, and vestiges of purposeful distillation can be traced back to the Stone Ages
(Gately, 2008).
Ethanol’s chemical nature poses special implications for pregnant women as
ethanol can diffuse through the placental barrier to interfere with healthy fetal
development (Guerri & Sanchis, 1985). Despite the long association between humans
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and alcohol consumption, the effects of exposure to alcohol in utero weren’t delineated
in the medical literature until the late 1900s. French pediatrician Paul LeMoine first
described alcohol-derived birth defects in 1968 after documenting 127 case studies of
children from alcoholic mothers (LeMoine, 1968). These effects included miscarriages,
stillbirths, growth retardation, and a constellation of facial malformations. Five years
later, American pediatricians Jones and Smith independently categorized the effects of
alcohol exposure in utero with 8 case studies. This article by Jones and Smith (1973)
launched worldwide investigations into the impact of alcohol on the fetus (Koren, 2012).
By 1981, the U.S. Surgeon General responded to the emerging body of literature on
alcohol’s teratogenicity by advising no alcohol consumption during pregnancy (US
Surgeon General, 1981). As the bodies of literature on the variable effects of alcohol
exposure in utero have grown, classifications of these effects have expanded to
encompass this spectrum. These effects are diagnosed as fetal alcohol spectrum
disorders (FASD) with fetal alcohol syndrome (FAS) referring to the most severe cases.
Despite awareness of the teratogenic effects, alcohol remains a widely abused
substance throughout pregnancy. According to data from prenatal clinics and postnatal
studies, up to 30% of pregnant women drink during their pregnancy, and 2% binge drink
(CDC, 2012). Shockingly, these estimates have shown no decline in the last two decades.
As a result, FASD occurs in approximately 9.1 per 1000 live births with FAS occurring in
approximately 2 per 1000 live births. Statistically, this makes FASD the most preventable
source of neurological deficits in the United States (Abel, 1995; Sampson et al., 1997).
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While the effects of in utero exposure to alcohol are devastating at an individual
level, society also feels the weight of this burden. Every child born with FAS has a
staggering economic cost of $2 million, and the U.S. government spends over $4 billion
in annual care for FAS individuals (Lupton et al., 2004). These numbers increase
exponentially when economic costs are extended to the entire FASD spectrum. Many of
these costs are associated with the multiple cognitive and social secondary disabilities
with FASD children. These secondary problems include functional deficits in problem
solving, deficits in adaptive function, decreased intelligence quotients, trouble with the
law, alcohol and drug problems, executive function deficits, and inappropriate sexual
behavior (Streissguth et al., 2004). However, the most prominent secondary deficits
associated with FASD are attention deficits.
Forty-one to 94% of children with FASD will later be diagnosed with attentiondeficit/hyperactivity disorder (ADHD) (Bhatara, Loudenberg, & Ellis, 2006; Fryer et al.,
2007). Comorbidity with ADHD becomes increasingly prevalent with greater exposure to
alcohol in utero, indicating that alcohol directly interferes with the development of
attention networks (Bhatara, Loudenberg, & Ellis, 2006). In fact, neonatal attention
deficits may be a more sensitive indicator of potential in utero exposure to alcohol than
even the characteristic facial dysmorphology (Lee, Mattson, and Riley, 2004).
Not only are attention deficits common in FASD children, but onset of these
deficits are one of the earliest symptoms of cognitive impairments. Streissguth, Barr,
and Martin (1983) examined approximately 500 one-day-old infants with and without
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exposure to alcohol using the Brazelton Scale. The Brazelton Scale assesses neonatal
behavior in general, and some of the measures are associated with attention.
Socioeconomic status, marital status, age, education, and race were all accounted for to
rule out confounding factors. Maternal prenatal alcohol consumption was also assessed
to examine alcohol effects on a dose-response scale. Streissguth et al. discerned that
neonates from alcoholic mothers had significantly lower states of arousal, poor
habituation to environmental stimuli, and basic deficits in operant learning. This finding
provided concrete evidence that developmental problems in FASD children were
evident even on the first day of life. Early occurring deficits in attention could have a
dynamic impact on function, aggravating ontogenesis of cognitive skills that mature
later such as learning and social skills. As a result, early treatment options could
remediate developmental trajectories in FASD, ameliorating the astronomical impact at
both individual and societal levels.
Understanding how alcohol interferes with the development of attentional
networks and the phenotype of attention deficits in FASD children will inform treatment
strategies for this population. Therefore, this introduction will examine the relationship
between prenatal ethanol exposure and one of the most overt behavioral characteristics
of FASD: attention deficits. The literature on attention deficits in FASD will be reviewed
in the context of neurobehavioral theories on attention with the argument that FASD
children exhibit a unique phenotype of attention deficits that is detrimentally masked by
the indiscriminate diagnosis of ADHD. The unique phenotype of FASD children is argued
to be the result of distinct changes in underlying neural networks – data which has been
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elucidated by animal models of FASD. A rationale for the use of animal models of FASD
will be provided, followed by a discussion of disruptions in catecholaminergic
transmission in FAS in relation to networks of attention. Because attention deficits are
primarily treated with stimulant medications, mechanisms of action of the two primary
stimulant prescriptions, methylphenidate and d-amphetamine, will be compared and
contrasted in relation to attention deficits and FASD. This literature review will be
followed by a rationale for the current experiments which examined the impact of
ethanol and d-amphetamine on developing dopaminergic and noradrenergic systems.
The overarching hypothesis is that a chronic therapeutic dose of d-amphetamine
normalizes hypo-functioning dopaminergic and noradrenergic systems in a rat model of
FASD.
1.2 ATTENTION DEFICITS IN FASD
Attention is an abstract concept with multiple different subcomponents that
collectively facilitate the selection of relevant information and the suppression of
irrelevant information. Two models of attention have been used to describe the
phenotype of attention deficits in FASD populations: Posner (1980) and Mirsky (1991).
Posner’s model (1980) describes attention as a spotlight which highlights a point
of interest, then disengages and moves to an alternative point of interest. This analogy
describes functional components essential to the attentional process: alerting,
orienting, and executive function. Alerting prepares an organism for processing highpriority signals. Orienting is the ability to locate a stimulus within a visual or auditory
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field. Executive function is a heterogeneous term which describes cognitive control
mechanisms resulting in top-down decision making for the attentional spotlight.
Alerting and executive function deficits have been extensively documented in FASD.
At a neurological level, alerting is associated with global levels of arousal and is
driven by the noradrenergic system. This association has been tested at a physiological
level in regards to spatial processing. Noradrenergic afferents increase spatial
processing in the prefrontal cortex (PFC) by inhibiting inputs with similar spatial
properties, thereby suppressing stimuli that could conflict with the target of interest
(Wang et al., 2007). Children with FASD have different problems alerting to stimuli
compared to children with ADHD without FASD comorbidity. This distinction was
demonstrated by Kooistra et al. (2009) using a Go/No-Go task. In the Go/No-Go task
subjects are presented with a predictable stimulus to which they must respond quickly.
However, in a small subsection of the trials, subjects must inhibit their response (i.e.
“No-Go” trials). Because No-Go trials are rare, response inhibition is challenging. There
were two trial rates: a fast rate with short intervals between trials and a slow rate with
long intervals. ADHD children without FASD comorbidity are sensitive to the stimulus
presentation rate with more errors and variability in slower conditions. In contrast,
FASD groups had declining performance in fast-rate conditions. These data indicate that
children with FASD have more problems handling overstimulation whereas non-FASD
ADHD children have greater problems handling understimulation. Sensitivity to multiple
stimuli may reflect changes in noradrenergic arousal systems.
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Executive function deficits are identifiable even in the absence of facial
dysmorphology with FASD (Mattson et al., 1999; Green et al. 2009). Green et al. (2009)
assessed executive function using the Cambridge Neuropsychological Tests Automated
Battery (CANTAB) and determined that FASD individuals exhibited deficits in multiple
executive function domains including set shifting, general attention, strategy and
planning, and spatial working memory. These deficits in executive function were evident
even in the absence of facial dysmorphology, which is indicative of the most severe
cases of FASD. Linking these behavioral findings with neural substrates would suggest
that these deficits are paralleled by deficits in the monoaminergic systems. Indeed,
animal literature has demonstrated that alcohol exposure induces many monoaminergic
alterations. Similar to Greene et al. (2009), Mattson et al. (1999) used to the DelisKaplan Executive Function Scale to evaluate planning, cognitive flexibility, selective
inhibition, and concept formation and reasoning in children with FASD compared to
children not exposed to alcohol in utero. Deficits in executive function were evident in
FASD populations even after deficits in intelligence quotients (IQ) were accounted for.
Additionally, deficits in executive function were evident in FASD children even when IQ
was within normal ranges. Collectively, these results indicate that executive function
domains are especially sensitive to the teratogenic effects of alcohol.
Another model of attention was proposed by Mirsky in 1991 (Mirsky, 1991). In
this model, attention is comprised of four primary elements: focus, sustain, encode, and
shift. Focus describes the ability to select information for further, higher-level
processing. Sustain describes the capacity to maintain focus over the course of time.
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Shift describes flexibility in attention, such as the ability to adaptively change focus.
Encode describes the ability to use working memory to manipulate information and
then transfer that information into long-term memory. According to Mirsky, these
elements could be partially functionally localized to discrete brain regions. For example,
Mirsky associated attentional shift with the prefrontal cortex, encoding with the
amygdala and hippocampus, focus with the inferior parietal lobe, and sustained
attention with the reticular formation in the brainstem. Using Mirsky’s model, clinical
diagnoses of attention deficits can be associated with specific brain regions, providing
targets for both research and clinical intervention strategies.
In 2006, Mattson, Calarco, & Lang used Mirsky’s model to examine attention in
FASD populations. Mattson and colleagues demonstrated that FASD children have
difficulty with attentional shift, visual focused attention, and sustaining auditory
attention, indicating that attention deficits in FASD extend across many measurable
domains. Mirsky’s model also provided a basis for comparing attention deficits between
FASD populations and ADHD populations without FASD comorbidity. These
comparisons, which will be discussed in the following section, are part of a movement to
distinguish a unique cognitive profile of FASD populations that can inform treatment
paradigms.
Both Mirsky and Posner created models that attempted to subdivide attention
into specific components and then functionally localize those components to specific
neural systems and brain regions. These models have provided useful templates for
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examining attention deficits in the FASD literature from a clinical perspective, informing
experimental models. However, the phenotype of attentional deficits in FASD
populations may change across development.
Hypersensitivity to environmental stimuli and poor habituation are early
indicators of attentional problems (Streissguth et al., 1983). These deficits in habituation
shift into attention deficits, as measured by classical attention-based tasks, during early
school years, and later in life these basic attention deficits become superseded by more
complex behavioral problems (Streissguth, Martin, & Barr, 1984; Fryer et al., 2007).
Evidence suggests that attention deficits are especially deleterious to development in
FASD populations. When examined in conjunction, comorbidity of FASD and ADHD has a
synergistic effect on future comorbidities (Ware et al., 2013). Specifically, oppositional
defiant disorder and conduct disorder had a far greater prevalence in ADHD-FASD
comorbid populations than ADHD populations without FASD or FASD populations
without ADHD (Ware et al., 2013). Lastly, secondary disabilities increase with age in
untreated populations of FASD (O’Malley & Nanson, 2002).
These data suggest that an attentional profile in FASD populations is a
developmental issue. Understanding manifestations of attention deficits in FASD and
the differentiation of those attention deficits from ADHD populations without FASD
comorbidity may provide insight to the impact of different treatments on general
prognosis. Therefore, this next section will focus on attention deficits in FASD and how
they compare to attention deficits in ADHD.
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1.3 THE UNIQUE PHENOTYPE OF ADHD IN FASD POPULATIONS
Diagnosis of ADHD in FASD populations reflects different attentional subtypes
than ADHD populations without FASD comorbidity. The Diagnostic Statistical Manual of
Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013) identifies 3
major domains in ADHD: (a) Inattentive subtype, (b) hyperactive and impulsive subtype,
or (c) a combined subtype. Diagnosis of ADHD in FASD populations preferentially reflects
inattentive subtypes over hyperactive and impulsive subtypes (O’Malley & Nanson,
2002). These results support the idea of a unique attentional profile of FASD children
with ADHD. Over the last decade, studies have increased efforts to document
distinctions between the progression and manifestation of attention deficits in FASD
children and ADHD with the hope that understanding these distinctions can inform
treatment of FASD children.
One of the earliest studies comparing attention deficits in FASD versus non-FASD
populations with ADHD was performed by Coles et al. in 1997. Coles et al. (1997)
demonstrated that while children with ADHD but not FASD are best identified using
measures of focused and sustained attention, children with FASD appear to have
greater visual and spatial reasoning deficits, encoding deficits, deficits in attentional
shift, and impaired flexibility in problem solving tasks.
Crocker et al. (2011) supported differential patterns of cognitive deficits
between ADHD and FASD children in a study that matched groups on age, sex, race, and
ethnicity, handedness, and socioeconomic status. FASD children had greater difficulty
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with encoding of information whereas ADHD children had greater difficulty with
retrieval. Burden et al. (2010) supported neural distinctions of FASD and ADHD
populations without FASD comorbidity using event-related potentials (ERPs) during a
Go/No-Go task. Although children with FASD performed similarly to those with ADHD
but no FASD comorbidity, ERPs varied between groups, indicating differences in neural
processing. These distinctions likely reflect differences in underlying neural networks,
indicating that attention deficits in FASD populations should not be treated the same as
ADHD without FASD comorbidity. Indeed, some evidence suggests that children with
FASD respond preferentially to d-amphetamine compared to methylphenidate stimulant
treatment for attention deficits (O’Malley, 2000). This distinction is not reflected in
ADHD populations without FASD where methylphenidate is the primary treatment
option (Zito et al., 2000; Goldman et al., 1998). The relationship between neural
networks, attention deficits, and treatment strategies need to be further examined so
neural networks can inform treatment of attention deficits in FASD. Because
understanding alcohol’s impact on neural networks has primarily been examined using
animal models, the next section will examine animal models of FASD.
1.4 ANIMAL MODELS OF FASD
A variety of animal models can be used to assess the impact of alcohol exposure
in utero. These models include zebrafish, rodents, and non-human primates (Patten,
Fontaine, & Christie, 2014). Rodent models are the most frequently utilized as they
display high levels of face and construct validity: deficits in rat models of FASD parallel
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deficits in human models. These parallels extend from physical to neurocognitive and
behavioral domains. Facial dysmorphology in mice is consistent with human facial
dysmorphology (Lipinski et al., 2012). Mouse models demonstrated that this
characteristic of FASD is dependent upon early gestational exposure (Parnell et al.,
2009). Rat models also display impairments in attention, learning impairments, and
hyperactivity, demonstrating symmetry between attentional phenotypes in humans and
rats (Hausknecht et al., 2005; Melcer et al., 1994; Stoltenburg-Didinger & Spohr, 1983).
Rodent models provide several advantages for studying alcohol exposure
compared to human studies of FASD. Studies of fetal alcohol exposure in humans have a
number of confounding factors. These factors include but are not limited to
socioeconomic status, multidrug use, racial differences, genetic predispositions,
unreliable reporting of drinking patterns, and environmental stress. In addition, human
studies of fetal alcohol exposure are ethically limited as humans cannot be assigned to
drinking and non-drinking pregnancy groups. This makes causal relationships between
ethanol and behavior impossible to determine. Animal models enable a randomized and
highly controlled examination of how ethanol impacts trajectories of
neurodevelopment, but in order to replicate human drinking behaviors, several factors
must be addressed.
One major consideration is that human development does not perfectly align
with rat development with respect to timing of birth (Bayer et al., 1993; Dobbing &
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Sands, 1979). A comparison of human and rat developmental periods can be found in
Table 1.1.
Exposure paradigms in animal models vary across gestation. The third trimester
of development (PD 1-10) is especially critical as this is considered the brains growth
spurt (Dobbing & Sands, 1979; Bonthius & West, 1991). There is evidence from both
animal models (Kelly et al., 1988; Maier et al., 1997; West, Kelly, & Pierce, 1986) and
also human studies (Rosett, 1981) that the third trimester is a period when the brain is
particularly vulnerable to insults including ethanol. The current study used a thirdtrimester paradigm for alcohol exposure. This exposure paradigm uses intragastric
intubation, delivering an alcohol-milk enriched mixture directly into the stomach of the
neonatal rat pups (Kelly & Lawrence, 2008). Alcohol exposure in neonatal rats can result
in nutritional deficits as the ethanol-exposed pups do not nurse properly. In order to
compensate for any malnourishment, a second, vitamin-rich intubation should be
performed. This limits neural deficits to alcohol, specifically.
A second consideration for animal models is how to accurately replicate human
patterns of drinking behavior. The most deleterious type of drinking for fetal alcohol
development is binge drinking as high blood alcohol concentrations increase the
severity of neural deficits (Bonthius, Goodlett, & West, 1988). Intubation procedures
can replicate this drinking pattern with minimal stress to the rat. This type of
administration allows precise oral doses of alcohol with rapid peak blood ethanol
concentrations (BEC) which is then eliminated through zero-order effects, as in humans.
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Intubated control groups who do not receive an ethanol solution provide comparisons
for the stress effect. Therefore, having three exposure groups (i.e. ethanol treated,
intubated control, and non-treated control) is essential to examining the effects of
alcohol on neurodevelopment and later behaviors.
Rats are well-suited for behavioral studies due to the plethora of behavioral
measures that are well established with the species (Cudd, 2005). However, several
studies suggest that female rats may be more vulnerable to chronic consequences of
prenatal alcohol exposure than males, especially in regards to behavioral dysfunctions
(Kelly et al., 1988; Grant et al., 1983). Kelly et al. (1988) demonstrated that spatial
navigation was selectively impaired in females during a Morris water maze task. Females
also are typically more active in the Open Field Test than males (Blizard, Lippman, &
Chen, 1975). The open field test is highly relevant to ADHD literature as it assesses
hyperactivity with locomotor behaviors as well as well as general levels of anxiety.
Hyperactivity in rat pups exposed to alcohol in utero corresponds with human clinical
literature (Riley, 1990). Several studies have assessed hyperactivity patterns in rat
models of FASD with mixed results. Melcer et al. (1994) demonstrated that males and
females exposed to high doses of alcohol during postnatal days 4-9 exhibited
hyperactivity by postnatal day 18. In contrast, Grant, Choi, and Samson (1983)
demonstrated that male rats exposed to ethanol demonstrated no behavioral
differences in open field activity. However, female rats neonatally exposed to ethanol
demonstrated more hyperactivity than female controls. This suggests that females may
be more behaviorally sensitive to the teratogenic effects of alcohol. Consequently, the
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current study focused on the effects of alcohol exposure on female rats in the open field
test as a model of an early precursor of attention deficits – hyperactivity.
1.5 LINKING THE CATECHOLAMINES IN FASD TO ATTENTION DEFICITS
Attentional processes are intimately linked with the catecholamine
neurotransmitters. Catecholamines are a subdivision of monoamine neurotransmitters
that consist of a catechol nucleus (i.e. a benzene ring with two hydroxyl groups) and an
amine side chain (i.e. NH2) (Horn, 1973). Within the catecholamine group, dopamine
and norepinephrine are particularly essential for regulation and modulation of attention
networks (Clark & Noudoost, 2014). These two neurotransmitters work in tandem with
subcortical and cortical networks to mediate various aspects of attention and
hyperactivity. Some evidence suggests that selective lesions of these neurotransmitter
systems impair attentional processes as severely as surgical ablation of the cortex
(Brozoski et al., 1979). In FASD populations, hypofunctioning of catecholamine systems
may generate similar attention deficits. Conversely, stimulant medications that increase
synaptic catecholamine levels can enhance attention at low-doses (Berridge et al.,
2006). In FASD populations, stimulant medications may normalize catecholamine levels,
improving attention and hyperactivity (Figure 1.1). This section will focus on the impact
of dopamine and norepinephrine on attentional networks in relation to FASD.
Subsequent sections will then discuss the role of stimulant medications in FASD.
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1.5.1 DOPAMINE AND ATTENTION NETWORKS IN FASD
Dopamine (DA) neurons originate from two distinct nuclear groups within the
brainstem: the ventral tegmental area (VTA) and the substantia nigra (SN) (Swanson,
1982). Neurons in the ventral tegmental area project to the nucleus accumbens (NAcc)
and the prefrontal cortex, making up the mesolimbic and mesocortical pathways,
respectively (Swanson, 1982). Neurons in the SN innervate the striatum, making up the
nigrostriatal pathway (Swanson, 1982). Collectively, these pathways mediate a variety of
functions including attention, working memory, reward salience, motivation,
movement, and learning (Schultz, 1992; Sawaguchi & Goldman-Rakic, 1991; Wise,
2004). Deficits in dopamine could mediate a wide range of behavioral deficits seen in
FASD populations, and the specific deficit may be pathway specific.
1.5.1A DOPAMINE IN WHOLE BRAIN
Early models assessing the relationship between dopamine and attention used 6hydroxydopamine (6-OHDA) to ablate vast areas of subcortical and cortical
dopaminergic networks. These lesion studies resulted in broad impairments in cognitive
performance, including attention. One of the earliest experiments to associate
dopamine with cognitive performance was performed in 1979 by Brozoski and
colleagues. In this study, rhesus monkeys depleted of dopamine were tested on a spatial
delayed alternation performance task. Dopamine-depleted monkeys performed more
poorly than controls on this task. More importantly, performance was rescued with
dopamine agonists (e.g. L-DOPA and apomorphine). This experiment was the first to
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establish a causal link between dopamine and cognitive performance. Additionally, it
demonstrated that pharmacological manipulations aimed at increasing dopamine in
dopamine-deficient models can abate cognitive deficits. If dopamine deficiency is an
underlying cause of attentional deficits in FASD, this suggests that drug treatment aimed
at augmenting dopaminergic networks may be beneficial.
Like lesion studies, the earliest examples of dopamine deficiency in fetal alcohol
models analyzed global dopamine neurochemical profiles from whole brain
homogenates. These studies used a liquid-diet paradigms of alcohol exposure, which
have concerns of malnutrition and dosage (Bonthius & West, 1988). Despite these
concerns, liquid-diet studies provided an important precedent for future studies on the
interaction between ethanol and developing dopaminergic systems. One of the first
studies of dopamine content following a dam-fed liquid diet paradigm during pre and
postnatal development was by Detering and colleagues in 1980. Detering et al. (1980)
determined that dopamine was significantly reduced in ethanol-treated pups by 21 days
of age. However, in this study, Detering et al. suggest that the decrease in dopamine
may be linked to malnutrition rather than alcohol effects because the effect was also
evident in the isocaloric matched control group. In 1996, Maier et al. reassessed the
impact of alcohol on dopamine and its metabolites using a binge-drinking paradigm of
prenatal alcohol exposure (Maier et al., 1996). This paradigm more accurately reflects
maternal drinking behavior in humans. Maier et al. demonstrated that dopamine and
one of its metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC), were reduced in whole

17

brain homogenates of ethanol-exposed rat pups following both chronic exposure
throughout gestation and a single-dose at gestational day 20.
1.5.1B DOPAMINE IN STRIATAL AND FRONTAL CIRCUITS
In an attempt to examine brain region-specific changes in dopamine levels,
Rathbun & Druse (1985) examined dopamine and its metabolites, DOPAC and
homovanillic acid (HVA), within specific brain homogenates: hypothalamus, cerebellum,
cortex, brain stem, striatum, and hippocampus. Rathbun & Druse (1985) demonstrated
that dopamine levels varied by both age and brain region following a prenatal liquid diet
paradigm of alcohol exposure. Developmentally, DA content increased in the
hypothalamus and striatum between 19 and 35 days while DOPAC and HVA levels
decreased in the striatum and increased in the cortex in controls. Across this same
developmental window, DA and HVA levels decreased in the cortex in ethanol-exposed
rats. These data provided 3 important pieces of information: 1) ethanol impacts the
developmental trajectory of dopaminergic systems, and therefore dopamine levels
cannot be assessed as static constructs, 2) the periadolescent developmental window
may be an important target for treatment due to the fluctuation in dopaminergic
networks during this time, and 3) ethanol may have the strongest impact on
mesocortical dopamine content.
Druse, Tajuddin, & Connerty (1990) supported the idea that ethanol impacts
dopaminergic systems in a developmental manner. Druse et al. (1990) examined the
impact of impact of a liquid ethanol diet during gestation on postnatal development of
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dopaminergic networks. Results indicate that ethanol severely impacts striatal and
frontal dopaminergic systems. Striatal dopamine exhibited a transient (44%) deficiency
during periadolescence. Frontal dopaminergic systems were also impaired in a transient
developmental manner: D1 receptors were reduced by 40% at postnatal day 19 but
normalized by postnatal day 37 in ethanol-exposed rats. Cortical D1 receptors are
especially important for attentional processing (Vijayraghavan et al., 2007). Stimulation
of D1 receptors reflects an inverted-U shape on attention with both high and low levels
of D1 stimulation being associated with poor allocation of attention (Vijayraghavan et
al., 2007). From a physiological level, low levels of firing of dopaminergic neurons
enhance spatial tuning, whereas high levels of firing are overwhelming and impair
processing of spatial stimuli. An analogy is that dopamine modulates levels of “noise”
within attentional networks (Clark & Noudoost, 2014). Early deficiency in dopaminergic
systems in FASD may underlie shifts attention profiles in FASD in an age-dependent
manner.
Other studies have examined on the dopamine transporter (DAT) and tyrosine
hydroxylase (TH) as opposed to post-synaptic markers. DAT is the primary means of
removing dopamine from the synaptic cleft in subcortical circuits, and TH is the ratelimiting step in dopamine synthesis. TH and DAT provide important information on
dopamine synthesis and clearance. Barbier et al. (2009) found that perinatal ethanol
from a liquid diet paradigm decreased striatal levels of DAT. This study is in agreement
with a study by Szot et al. (1999) which demonstrated that prenatal ethanol exposure
via a liquid diet paradigm results in a decrease in DAT messenger ribonucleic acid
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(mRNA) in the SN and VTA in adult male rats. TH mRNA was also decreased in the VTA
(Szot et al., 1999). Collectively, these data suggest that dopamine synthesis and synaptic
clearance are hypofunctioning in nigrostriatal and mesolimbocortical circuits in FASD
models.
Prenatal ethanol also induces morphological changes in the mesocortical and
nigrostriatal dopaminergic system. Shetty, Burrows, & Phillips (1993) reviewed the
effects of the perinatal ethanol exposure in rats on dopaminergic structure in the SN
using a Golgi-Cox stain. Specifically, Shetty et al. demonstrated that perinatal ethanol
exposure in rats resulted in smaller and more densely packed dopaminergic somata,
decreased dendritic arborization, decreased dendritic branch length, and dysmorphic
development of these dopaminergic neurons. The impact of prenatal alcohol exposure
on structure, neurochemistry, and morphology of dopamine neurons is consistent with
the hypothesis of a hypofunctioning dopaminergic system underlying attention deficits
in FASD. A hypofunctioning dopamine system may underlie symptoms of hyperactivity
as well as poor reduction of “noise” when attending specific stimuli.
1.5.1C DOPAMINE IN THE MESOLIMBIC SYSTEM
Cortical and subcortical dopaminergic pathways interact with each other
dynamically. Lesion studies have demonstrated that cortical depletion of dopamine is
paralleled by mesolimbic hyperactivity in dopaminergic neurons, indicating a functional
link between these two systems (Nieoullon, 2002). In terms of cognitive performance,
deficits in dopamine-mediated prefrontal cortical function could reflect poor inhibitory

20

control of sensory information and a decreased ability to instigate appropriate motor
responses (Russell et al., 1995). In conjunction, deficits in dopaminergic function in the
nucleus accumbens may distort signals of reward-based stimuli, altering salience values
and influencing attention to these stimuli (Sonuga-Barke, 2005). In measurements of
attention, alterations within the mesolimbic system results in reductions in response
speed and vigor (Robbins & Everitt., 2007).
FASD models have demonstrated structural and functional deficits in mesolimbic
dopamine systems. In 1993, Blanchard et al. used in vivo microdialysis to examine
mesolimbic dopaminergic response to alcohol following prenatal exposure to alcohol
(Blanchard et al., 1993). Ethanol-exposed rats showed a dopamine response equivalent
to controls in the nucleus accumbens and striatum following a low dose of alcohol
administration. At higher doses, males showed the expected increase in dopamine in
response to alcohol in both structures. However, females showed no reaction in the
nucleus accumbens and a decrease in dopamine levels in the striatum. These data
indicate 1) that neurochemical changes in the dopaminergic system following prenatal
alcohol exposure are both sex and brain-region specific, and 2) that neurochemical
decrease in dopamine may be more marked in females, further supporting the
examination of females in the current study.
Functional differences in stimulus-driven dopamine activity within mesolimbic
circuits are supported by a series of electrophysiological studies on dopaminergic firing
patterns (Shen, Hannigan, & Chiodo, 1995; Shen, Hannigan, & Kapatos, 1999). In 1999,
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Shen, Hannigan, & Kapatos demonstrated that rats exposed to alcohol prenatally via an
intragastric intubation binge-drinking paradigm had a reduction in spontaneously active
dopaminergic firing within the mesolimbic circuit. Using tyrosine-hydroxylase based cell
counts, Shen and colleagues determined that this reduction is not due to dopaminergic
cell loss, and this reduction is persistent throughout adulthood. This reduction in
spontaneous firing patterns of DA neurons was only seen in ethanol-treated rats and
not in intubated controls, indicating that any changes are specific to the ethanol
treatment and not due the stress from the intubation procedure.
Collectively, these studies suggest attentional deficits in FASD may reflect
impairments in different dopaminergic pathways. Interactions between mesolimbic
input and executive regulation of attention in the prefrontal cortex is of special interest
in FASD. In FASD populations, hypofunctioning of dopaminergic neurons may result in
poor tuning of spatial stimuli, thereby impairing attentional modalities such as “shifting”
of attention. Because stimulant treatments acutely increase striatal and mesolimbic
dopamine levels, spatial tuning may be normalized following stimulant treatment in
FASD populations.
1.5.2 NOREPINEPHRINE AND ATTENTION NETWORKS
Noradrenergic afferents originate from the locus coeruleus in the brainstem and
project to various cortical regions where they modulate a variety of functions. In the
prefrontal cortex, noradrenergic afferents influence attention and vigilance by honing
neuronal responses to stimuli in attended directions (Rajkowski et al., 2004). Rajkowski
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et al. (2004) demonstrated that noradrenergic neurons in the locus coeruleus are
phasically activated in response to target stimuli, and that this response occurs prior to
any behavioral action, indicating that noradrenergic responses are closely linked to the
presentation of sensory stimuli. This suggests that attention towards motivationally
driven targets is modulated by phasic noradrenergic activity from the locus coeruleus.
Because firing patterns varied with stimuli presentation and behavioral reaction time,
Rajkowski et al. postulated that norepinephrine (NE) is an important facilitator of
behavioral responses to attended stimuli by rapidly reorganizing neural networks in
response to sensory stimuli. In other words, phasic firing of noradrenergic neurons
allows adaptation to the changing environment that is imperative to selective
attentional processes.
Like DA, the relationship between NE and attention exhibits an inverse-U shape
(Figure 1.1) where low and high NE is associated with impaired attentional states
(Arnsten & Pliszka, 2011). In relation to FASD populations, low levels of NE in the
prefrontal cortex may be associated with low “signals” for motivationally driven stimuli,
thereby facilitating inattentive phenotypes of ADHD. Examining markers of
dopaminergic and noradrenergic neurotransmitter systems within mesolimbic and
cortical regions may help elucidate some of the underlying mechanisms distinguishing
attentional profiles in FASD populations.
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1.5.4 NORADRENERGIC SYSTEMS IN FASD
Norepinephrine (NE) is very similar in structure to DA, and in fact, there is some
overlap in receptor binding between these two catecholamines. Noradrenergic neurons
use dopamine β-hydroxylase to transform DA into NE. As such, effects on levels of DA
content could have downstream effects on NE. In addition, because DA works in tandem
with NE to modulate attention, it is important to understand if ethanol differentially
affects these neurotransmitter systems.
Effects of prenatal alcohol exposure on noradrenergic neurons have been mixed.
Results in animal models appear to be dependent upon windows of exposure to alcohol,
brain region, alcohol exposure paradigm, and postnatal treatment. Some of the earliest
work on the impact of ethanol on developing catecholamine systems came from
Detering and colleagues. Detering et al. (1980) demonstrated that NE levels were
significantly lower in whole brain regions of rats prenatally or postnatally exposed to
alcohol. This result was replicated by Sari et al. in 2010. Sari et al. demonstrated that
ethanol exposure at early embryonic stages (gestational days 7-13) in mice results in a
reduction in whole-brain concentrations of norepinephrine via liquid chromatography,
indicating that the effects of alcohol on noradrenergic systems are visible even at the
earliest developmental windows.
In contrast, Rudeen & Weinberg (1993) did not find any differences of
norepinephrine concentrations among liquid-diet ethanol exposed groups compared to
pair-fed and ad libitum-fed control groups in any brain region during resting behavioral
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states. Rather, differences between neurotransmitter systems became apparent after
stressors. Following a single exposure of restraint stress, NE concentrations were
reduced in the cortex and hypothalamus but elevated in the hippocampus of rats
exposed to ethanol relative to both control groups. Following chronic restraint stress,
NE levels were decreased in the cortex of ethanol-exposed rats relative to both control
groups. Because these effects varied by brain regions, whole brain measures may
inadequately discern the more complex effects of alcohol on developing systems.
Rudeen & Weinberg also noted sex differences in response to alcohol exposure: females
exposed to ethanol exhibited greater reductions in noradrenergic content than males.
This indicates that females may be especially sensitive to the effects of ethanol on
noradrenergic transmission.
Disagreement between Rudeen & Weinberg (1993), Sari et al. (2010), and
Detering (1980) may be due to differences in exposure and brain region. Although all
studies used liquid-diet paradigms of alcohol exposure, Detering et al. (1980) examined
whole brain homogenates whereas Rudeen & Weinberg (1993) partitioned specific brain
regions. One possibility is that global changes in noreprinephrine levels may be due to
brain regions not measured by Rudeen & Weinberg. Disagreement between Rudeen &
Weinberg (1993) and Sari et al. is likely due to time since exposure. Because Sari et al.
(2010) examined norepinephrine levels after shortly after alcohol exposure, the effects
from Sari et al. may be transient.
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Because early studies often focused on liquid-diet paradigms of alcohol exposure
during prenatal periods, Tran and Kelly (1999) examined the effects of early postnatal
exposure on neurotransmitter systems using a binge-drinking paradigm. As postnatal
exposure corresponds with the brain growth spurt, it is a critical period for the
development of neural systems. Early postnatal alcohol exposure was associated with
an increased in NE concentrations in the hippocampus. Early postnatal alcohol exposure
effects were greater for females than males, again indicating that females may be more
susceptible during this developmental window. In 1999, Tran and Kelly sought to
connect disjointed literatures with varying exposure timelines. Using high-performance
liquid chromatography, Tran and Kelly demonstrated that NE levels were increased in
the hippocampus in both males and females following a three-trimester paradigm of
alcohol exposure. These data indicate that binge-drinking paradigms during postnatal
exposure or during all three trimesters will impact norepinephrine levels in a brainregion and sex-dependent manner.
For attention, noradrenergic systems within the prefrontal cortex are especially
critical. Zimmerberg and Brown (1998) examined the effects of prenatal alcohol on
plasma concentrations of NE in the prefrontal cortex using a liquid diet paradigm of
prenatal exposure. Results indicate that NE is decreased in the prefrontal cortex
compared to chow-fed controls, but an increase in NE compared to pair-fed controls.
There was no effect of alcohol on NE levels in the NAcc or striatum. Like previous
results, these data indicate that alcohol exposure impacts catecholamine levels in a
brain-region-dependent manner and that certain brain regions may be more vulnerable
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to the effects of alcohol exposure than others. Because noreprinephrine is important for
enhancing relevant signals within the prefrontal cortex during attention tasks,
decreased norepinephrine levels in this brain region in FASD models may be responsible
for inattentive behaviors in FASD populations.
1.6 TREATING ATTENTION DEFICITS: AN EXAMINATION OF STIMULANT MEDICATIONS
Stimulant medications are the most common and effective treatment for
attention deficits. Stimulants comprise a class of psychoactive drugs that augment
neural activity, increasing mood, awareness, and alertness. Two primary stimulants are
methylphenidate (Ritalin) and d-amphetamine (Adderall). Although both
methylphenidate and amphetamine increase monoamine levels, their mechanisms of
action are distinct. Methylphenidate is part of a class of monoamine blockers whereas
amphetamine is a monoamine releaser. Blockers obstruct the catecholamine
transporters DAT, the noradrenergic transporter (NET), and the serotonin transporter
(5-HTT). These transporters are important regulators of extracellular monoamine levels.
They bind DA, NE, and serotonin (5-HT) in order to remove them from the synaptic cleft
and transport them back into the cytosol of the presynaptic neuron. Blocking this
mechanism acutely increases synaptic levels of DA, NE, and 5-HT for postsynaptic
receptor binding, resulting in augmented signaling. Because methylphenidate inhibits
monoamine reuptake after release, its efficacy is dependent upon classic actionpotential driven release from vesicular pools.
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Unlike methylphenidate, amphetamine is a releasing agent. Therefore,
amphetamine is not dependent upon classic action-potential mediated release. Instead,
amphetamine acutely reverses the directional functioning of transporters. This includes
DAT, NET, 5-HTT, and an intracellular transporter known as the vesicular monoamine
transporter-2 (VMAT-2). VMAT-2 transports monoamines from the cytosol into synaptic
vesicles where they await action-potential mediated synaptic release (Riddle,
Fleckenstein, & Hanson, 2005). These vesicular transporters are dynamic regulators of
vesicular load, where their functional effects have direct influences on how much
neurotransmitter is released during synaptic transmission (Eiden, 2000). Amphetamine
reverses VMAT-2 by disrupting the vesicular pH gradient. As a result, monoamines that
are packaged into synaptic vesicles are re-released into the cytosol (Sulzer & Rayport,
1990; Sulzer et al., 1995). Because amphetamine also reverses membrane-bound
transporters (i.e. DAT, NET, 5-HTT) by initiating an inward-facing conformation change,
the cytosolic monoamines bind to the now-inward facing transporters and are reversetransported into the synaptic cleft (Chen et al., 2010). This results in the force-released
mechanism of monoamines. Therefore, a critical difference between methylphenidate
and amphetamine is that methylphenidate efficacy is dependent upon tonic release of
dopamine while amphetamine is not (Fleckenstein et al., 2007).
As a result, amphetamine has a much greater effect on extracellular DA, NE, and
5-HT levels than methylphenidate. Using microdialysis, Kuczenski & Segal (1997)
demonstrated that a 10 mg/kg dose of methylphenidate increases extracellular DA
levels in the caudate/ putamen to a concentration of 100 nM whereas a 2.5 mg/kg dose
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of amphetamine increased DA to nearly 500 nM with peak effects at 30 minutes after a
subcutaneous injection. Hippocampal levels of NE also significantly increased with
amphetamine relative to methylphenidate. 5-HT levels were also more impacted by
amphetamine than methylphenidate. However, both drugs exhibited the greatest
impact of extracellular levels of DA.
Although both methylphenidate and amphetamine increase synaptic levels of
monoamines through similar mechanisms, children diagnosed with FASD+ADHD and
ADHD without FASD comorbidity respond differently to these treatments (O’Malley,
2000). Approximately 90% of preschoolers diagnosed with ADHD are prescribed
methylphenidate (Goldman et al., 1998; Zito et al., 2000). However, evidence suggests
that children co-diagnosed with FASD and ADHD have a more positive clinical reaction
to amphetamine (O’Malley, 2000). O’Malley conducted a pilot study of 30 patients with
ADHD and FASD. These patients received treatment with either amphetamine or
methylphenidate. Nineteen of the 30 patients responded positively to amphetamine
whereas only 5 responded well to methylphenidate. In addition, 8 patients who were
treated with methylphenidate had negative responses and had to be switched to
amphetamine; these patients responded positively to amphetamine. Only one patient
responded preferentially to methylphenidate over amphetamine, and 3 patients
responded poorly to both methylphenidate and amphetamine. These results indicate an
increased efficacy for amphetamine treatment compared to methylphenidate treatment
in FASD clinical populations.
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Other results on stimulant intervention for attention deficits in FASD are mixed.
Oesterheld et al. (1998) examined the effectiveness of methylphenidate in Native
American Children with FASD. FASD children were randomly assigned methylphenidate
or a placebo for 5 consecutive days. Although methylphenidate significantly improved
hyperactivity, attention scores were not improved. Because this study did not compare
methylphenidate to amphetamine, it is unclear whether amphetamine would have
succeeded where methylphenidate failed.
1.6.2 DEVELOPMENTAL PERSPECTIVES: TREATMENT DURING WINDOWS OF OPPORTUNITY
The time period for administration of amphetamine is critical to the types of
effects that are reported. Juvenile response to pharmacological treatments can be quite
different from the adult response. For example, juveniles have a decreased sensitivity to
the locomotor effects of stimulants. This is reflective of fluctuating changes in the
dopamine transporter during this period. Neurological systems in flux may react
differently to pharmacological interventions. In adult animals, drug exposure is followed
by a biological compensatory reaction that counteracts the pharmacologically induced
state. This process is known as the opponent process. However, when neural systems
are still maturing, such as during the juvenile developmental window, pharmacological
effects can induce permanent neurodevelopmental changes that persist long after the
drug administration has been ceased (Andersen, 2004). This process is known as
neuronal imprinting. Neuronal imprinting has exciting implications for pharmacological
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treatments. Pharmacotherapy targeted during specific developmental windows may
provide an opportunity to shape and normalize aberrant developmental trajectories.
In support of this theory, Choong & Shen (1999) demonstrated a reduction in
dopaminergic firing in the VTA following a prenatal paradigm of alcohol exposure. This
reduction of dopaminergic firing is not evident until four weeks of age and then persists
into adulthood. This suggests the possibility that early intervention paradigms that
target the transition period in firing patterns may be effective at shaping developmental
trajectories in FASD populations.
1.7 JUSTIFICATION OF STUDY
Noradrenergic and dopaminergic systems both play important and diverse roles
in attention. Both systems have been demonstrated to have deficits in FASD
populations, and the patterns of these deficits may reflect specific profiles of attention
deficits. Although each system has been assessed independently in the literature,
studying NE and DA congruently will provide a more holistic picture of attention
systems. There is some conflicting evidence on deficits in NE. This may be reflective of
variations in patterns of exposure. The current study proposes to use a third-trimester
model of exposure to isolate ethanol’s teratogenicity during the brain’s growth spurt.
This controlled paradigm will provide valuable additional information on the impact of
alcohol on developing neural networks.
Because catecholamine systems continue developing throughout adolescence,
extending studies across this developmental window is important for translation into
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clinical FASD literature. Rat models of FASD have suggested that hypofunctioning of
catecholamine systems may adversely impact developmental trajectories. Because
amphetamine directly increases synaptic NE and DA levels, amphetamine may rectify
this trajectory if administered during appropriate developmental windows. However,
neurotransmitter systems are still maturing throughout adolescence. This complicates
clinical understanding of the impact of chronic pharmacological treatments.
Understanding the impact of chronic amphetamine treatment in FASD populations
during the periadolescent developmental window will inform treatment paradigms in
clinical populations of FASD. Therefore, the current study addresses chronic
periadolescent amphetamine exposure in a rat model of FASD.
Lastly, rat models suggest that females may be more sensitive to the teratogenic
effects of ethanol, displaying greater hyperactivity than males. However, females are
often underrepresented in the animal literature. This study will therefore focus on the
impact of ethanol on female hyperactivity. Because hyperactivity is an early precursor to
more complex attentional deficits, locomotor behaviors will be assessed in an Open
Field Test at multiple developmental time points across periadolescent development.
These aforementioned pieces of information have been inadequately addressed
in the current literature. Therefore, the current study had three aims: 1) to investigate
the effects of neonatal ethanol exposure on DAT and TH in the NAcc, 2) to investigate
the effects of neonatal ethanol exposure on DBH in the prefrontal cortex, and 3) to
investigate the effects of chronic therapeutic doses of amphetamine treatment on DAT,
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TH, and DBH in the NAcc and PFC during a critical developmental window in a rat model
of FASD in females.
It was hypothesized that DAT, TH and DBH would be decreased in ethanoltreated rats compared to controls. Chronic exposure to amphetamine was hypothesized
to increase these markers in all groups. These changes were hypothesized to be
reflected in behavioral measures of hyperactivity: amphetamine treatment was
hypothesized to interact with neonatal treatment so that amphetamine reduces
hyperactive locomotor responses in ethanol-treated rats and exacerbates locomotor
responses in controls.
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Table 1.1
Comparison of human and rat developmental periods.

Human

Rat

First Trimester

Gestational days 1-10

Second Trimester

Gestational Days 11-22

Third Trimester

Postnatal Days (PD) 1-10
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Figure 1.1. Attentional Performance as an Inverted-U. Low or high levels of
DA/ NE result in impairments in attention. FASD is associated with
hypofunctioning of DA/NE systems and impaired attentional performance.
Amphetamine may improve attention in FASD populations by optimally
increasing catecholamine levels.
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CHAPTER 2
METHODS
2.1 DOSE-RESPONSE STUDY
This study had four levels of amphetamine treatment measured across a
repeated measure of day (PD 26 to 40). See Figure 2.1 for a timeline.
2.1.1 ANIMALS
Twenty-eight juvenile female Long-Evans rats were obtained at postnatal day 23
(PD 23) with day of birth counted as PD 1. Thirty-two rats were pair-housed in standard
polypropylene cages at the University of South Carolina School of Medicine’s animal
facility with ad libitum access to both standard food and water. Cages were changed
twice weekly with new bedding, fresh water, and additional food. The facility was
temperature controlled at 22°C and runs on a 12/12 h light-dark cycle with the light
cycle beginning at 07:00 h. Rats were handled and weighed daily (09:00 h) in order to
keep track of any effects on body weight effects due to the amphetamine treatment as
well as to accurate daily treatment dosages. These housing procedures were in
accordance to all guidelines and regulations by the University of South Carolina’s Animal
Care and Use Committee.

36

2.1.2 AMPHETAMINE TREATMENT
Each rat was randomly assigned to one of four treatment groups: water (H2O),
0.5
mg/kg/day d-amphetamine, 1 mg/kg/day d-amphetamine, and 2 mg/kg/day damphetamine (Sigman, amphetamine HCl). Each group had a total of eight rats.
Amphetamine doses were calculated based on the salt form of d-amphetamine. The
range of doses were set to accommodate for the full range spanning from doses
typically used in children (up to .6 mg/kg/day) (Wolraich & Shubiner, 2009) with the
higher dosages (up to 2 mg/kg/day) tested in the animal literature (Koffarnus & Katz,
2010; Bizot, David, & Trovero, 2011).
D-amphetamine was obtained from Sigma Aldrich (catalog number A5880-5G).
Solutions were prepared by dissolving with d-amphetamine in distilled H2O for a volume
of 1 mL/kg. The rats were injected subcutaneously twice a day at 10:30 h and again at
16:30 h in order to compensate for the short, 1 hour plasma half-life of d-amphetamine
in juvenile rats (Heijtz, Kolb, & Forssberg, 2003) compared to the longer, 4-6 hour halflife noted in children (Wolraich & Shubiner, 2009). Each injection was half of the total
daily dose for the designated treatment condition. Treatment lasted a total of 14 days,
beginning at PD 26 and culminating PD 40.
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2.1.3 BEHAVIORAL MEASUREMENTS
The rats were given an Open Field Test twice during the treatment paradigm to
assess motor hyperactivity. The first test was conducted on day PD 26, 30 minutes after
amphetamine treatment on the first day in order to discern baseline levels of activity
following acute drug administration. Timing was set in accordance with peak
amphetamine-induced dopamine efflux in the NAcc as determined by Schiffer et al.
(2006). The second test was conducted on PD 40, 30 minutes after the last treatment.
Each rat was transported to the behavioral testing room in an opaque transport cage
immediately prior to testing and then placed in a square 60 x 60 x 35 cm, gray Plexiglas
chamber for a total of 15 minutes. The floor of the chamber was divided into an inner
and an outer section, and an overhead video camera recorded the rat’s movements.
Lighting averaged 400 lux.
Total distance traveled and proportions of time spent in inner versus outer zones
were analyzed using Ethovision 7 (Noldus). Total distance traveled is the summation of
distance traveled in centimeters over the entire testing period. The inner zone was a
30×30 cm square zone defined as all areas medial to the perimeter (Figure 2.2). After
the testing procedure, the rat was returned to its cage. Between each test, the chamber
was wiped down with 5% ammonium hydroxide.
There are two major locomotor considerations due to the time course of this
study. The first is the normal developmental changes of locomotor behavior over time.
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The second is the potential of locomotor sensitization from chronic amphetamine
treatment.
2.1.4 STATISTICAL ANALYSES
Body weights were tracked throughout the experimental procedure as a
decreased body weight is a potentially adverse side-effect to chronic amphetamine
treatment. These data were analyzed by a repeated measures ANOVA with the factors
of day and treatment. Results for the Open Field Test were analyzed as a repeated
measures ANOVA. The four levels of treatment are as follows: H2O, 0.5 mg/kg AMPH, 1
mg/kg AMPH, 2 mg/kg AMPH. The repeated measures are the two levels of the factor
day (acute, chronic). For all data, outliers were replaced with mean values. Outliers were
defined as any value that is either above or below 2 standard deviations from the mean.
There were no outliers for the dose-response study. Due to a fire alarm interruption on PD
26, two rats were removed from analyses. One rat was from the medium amphetamine
dose group and the other was from the high amphetamine dose group. Statistical

significance was set at α = .05. To explore statistically significant main effects or
interactions, Tukey’s HSD post hoc tests were run.
2.2 FASD STUDY
Experiment 2 was a 2×2×3 between-groups design with 2 levels of drug
treatment (i.e. H2O, AMPH), 4 levels of day (PD 26, PD 27, PD 40, PD 41) and 3 levels of
neonatal exposure (i.e. NC, IC, ET). See figure 2.3 for a timeline.
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2.2.1 ANIMAL PROCEDURES: THE FASD MODEL
Timed-pregnant dams were ordered and individually housed in standard
polypropylene cages with ad libitum access to standard food and water. Housing and
animal maintenance were the same as those in the dose-response study. A total of 68
pups from each dam were randomly assigned in a split litter design to one of three
treatment groups: non-intubated controls (NC), intubated controls (IC), or ethanol
treated (ET). Day of birth for each pup was designated PD 1. The intubation procedure
consisted of Intramedic PE 10 tubing dipped in corn oil for lubrication purposes that was
lowered down the pup’s esophagus. Neonatal ethanol exposure lasted from PD 2 until
PD 10. The NC pups did not receive any intubations in order to control for the
procedure’s stress factor. IC pups were intubated twice daily without any administration
of solutions. ET pups received two daily intubations. The first intubation was between
09:00 h and 11:00 h and consisted of 3.0 g/kg ethanol in 27.8 mL/kg of enriched milk.
The second intubation was between 11:00 h and 13:00 h and consisted only of the
enriched milk in order to compensate for any malnutrition due to the lack of feeding
behaviors following the ethanol administration.
All pups were weighed and tattooed for identification on PD 7 (Animal
Identification & Machine Systems, Inc.). The pups remained with their dams until PD 21
upon which they were weaned and pair-housed with their same sex littermate. As in the
dose-response study, this study consisted only of females. The male pups from these
litters were utilized in a different experiment.
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2.1.2 BLOOD ETHANOL CONCENTRATIONS
Blood samples were collected from tail bleeds from IC and ET pups on PD 10 two
hours after the first intubation, which is optimal for assessing maximum BEC levels (Kelly
& Lawrence, 2008). Blood samples from the IC pups were used to create a standard
curve of specific BECs: 0, 50, 100, 200, 300, 400, 500, and 600 ng/mL. Blood was
collected into centrifuge tubes with 190 µL of 0.53 N perchloric acid. 200 µL of 0.30 M
potassium carbonate was then added to block coagulation. The samples were vortexed,
placed on iced, and then centrifuged at 4oC for 20 minutes. The supernatant was
removed and stored at -80oC until the assay was run. BECs were analyzed via an
enzymatic process using a 96-well plate according to previously established procedures
by Dudek & Abbott (1984). Samples and standards were run in duplicate with 50 µL of
sample, 400 µL of 1.86 mM Tris-NAD stock, and 50 µL of alcohol dehydrogenase added
to each well. The plate was briefly mixed on an orbital shaker and then incubated for
one hour prior to absorbance reading (340 nm). BEC values were interpolated from the
standard’s values.
2.2.3 AMPHETAMINE TREATMENT
Amphetamine treatment was conducted as described in the dose-response
experiment using the middle dose (1 mg/kg/day) as determined by the results from that
study. In this study there were two levels of treatment factor: H2O control versus
amphetamine.
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2.2.4 BEHAVIORAL ANALYSIS
Locomotor behavior was assessed with all 68 animals at four times in this study:
PD 26, PD 27, PD 40, PD 41. Procedures are identical to the dose-response experiment
with the test performed 30 minutes following the last d-amphetamine injection.
Two behaviors were measured in addition to locomotor activity as described in
the dose-response study: rearing, grooming. Rearing behavior is defined as both front
paws lifted simultaneously from the floor. This is used as a basic assessment of motor
stereotypy (Creese & Iversen, 1973). Grooming behavior can be an index of anxiety
(Dunn et al., 1987). Grooming was defined as cleaning of the paws or body. All tests
were analyzed blindly by the same experimenter, Victoria Macht, who has significant
history analyzing behavioral data. Forty-five videos were randomly selected to be
analyzed for rearing and grooming behaviors.
2.2.5 TISSUE PREPARATION AND ANALYSIS
Twenty-four hours after the last behavioral testing, the rats were anesthetized
with isoflurane in a bell jar and subsequently perfused with 0.9% saline followed by
~300mL of a double-filtered 4% paraformaldehyde in 0.1 M phosphate buffered
solution, pH 7.4. Following decapitation, the brains were removed and post-fixed in the
4% paraformaldehyde for 24 hours. Then the brains were placed in a 30% sucrose/0.1 M
phosphate buffered solution where they incubated for 48-72 hours at 4°C until they
sank. After sinking, they were transferred to cryoprotecting solution and then sliced on
a freezing microtome at a thickness of 40 µm into coronal sections. Tissue from two
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targets were separated during sectioning: the NAcc and the medial PFC. The NAcc was
defined anatomically by plates 10-15 from Paxinos and Watson’s (1998) rat brain atlas;
the medial PFC was defined anatomically by plates 8-10. Sections were collected serially
into four separate tubes and then tested for TH, DAT, and DBH content via
immunohistochemistry. TH and DAT immunohistochemistry was performed on tissue
from the NAcc; DBH immunohistochemistry was performed on tissue from the medial
PFC (Figure 2.4). Tissue from 43 rats was analyzed for DBH, tissue from 31 rats was
analyzed for DAT, and tissue from 35 rats was analyzed for TH.
Immunohistochemical procedures were performed at room temperature (~25°C)
unless otherwise specified. Each section was washed in Tris-buffered saline (0.1 M TrisHCL with 0.9% NaCl, pH 7.4) and then rinsed with methanolic peroxide to block the
endogenous peroxidase enzymes in the tissue. Next, the sections were blocked against
nonspecific staining and the membranes were permeabilized by incubating for 30-60
minutes in a solution of 0.3% Triton X-100 (TX), Tris-buffered saline (TBS), and 2%
normal goat serum (NGS).
The primary antibody for TH was a rabbit anti-tyrosine-hydroxylase IgG
polyclonal antibody from Millipore. Tissue was incubated in the primary antibody for 24
hours at a 1:5000 dilution at room temperature and then another 48 hours in the cold
room (4°C). Following the primary incubation, the tissue was rinsed in TBS and
incubated with a biotinylated donkey anti-rabbit IgG (1:1000) from Vector Laboratories,
Inc. for 1.5 hours at room temperature. Next, the tissue was re-rinsed in TBS and
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incubated for one hour in peroxidase-conjugated streptavidin (1:1600). Finally, the
tissue was rinsed in TBS, developed in a 0.05%, 3,3’ diaminobenzidine-HCl with Nickel
Chloride in TBS for 12 minutes, and then mounted on 0.3% gelatin-coated slides. Slides
were subsequently dried and dehydrated prior to cover-slipping.
DAT was measured using the same immunohistochemical procedure as TH. The
primary antibody was the DAT1 monoclonal rat anti-DAT IgG (1:1000) from Millipore.
The secondary antibody was a biotintylated horse anti-rat IgG (1:1000) from Vector
Laboratories, Inc. The tertiary remains peroxidase-conjugated streptavidin (1:1600).
DBH was also measured using the same immunohistochemical procedure as
described above. The primary antibody was a monoclonal mouse-anti-dopamine-betahydroxylase (1:3000). The secondary antibody was a biotintylated horse anti-mouse IgG
(1:1000) from Vector Laboratories, Inc. The tertiary remains peroxidase-conjugated
streptavidin (1:1600).
2.2.6 IMAGE J ANALYSIS
Each slide was observed under a light microscope with a digital camera
attachment. Pictures were saved as a TIFF file and processed in Image J, a free software
program from NIH (http://rsb.info.nih.gov/ij). The NAcc was identified on sections from
plate 12 as the area medial and adjacent to the anterior commissure. Images from the
NAcc were taken at a 20X magnification. The medial PFC was identified as the area
medial to the white matter from the corpus callosum. Images targeted neuronal layer
II/III, and these images were taken at a 10X magnification. A minimum of two images
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per section were processed. For all data, results were averaged so that only one data
point was attributed to each animal. Within each picture, immunoreactivity for TH and
DAT were assessed as average gray values using optical density via ImageJ. Each image
was 1392 ×1040 pixels which corresponds to approximately 0.64×0.48 mm at 10X
magnification and 0.32×0.24 mm at 20X magnification, respectively. Immunoreactivity
for DBH was assessed using a dichromatization method as described by Iritani et al.
(2010). With this method, an index of immunoreactivity is calculated automatically as
pixel units within the defined area (Figure 2.5).
2.2.7 STATISTICAL ANALYSIS
Results for the Open Field Test were analysis as a repeated measures ANOVA
(RMANOVA). There were two independent variables: exposure, treatment. Exposure
refers to the three levels of neonatal exposure: NC, IC, ET. The two levels of treatment
are H2O and AMPH. There are also four levels of time (i.e. PD 26, PD 27, PD 40, and PD 41).
Four dependent variables were assessed: total distance traveled, time spent in the inner
zone, rearing, and grooming. Immunohistological data were assessed by 2x3 ANOVAs. The
dependent variables in this case were DAT, TH, and DBH.
For all data, statistical significance was set at α = .05. Outliers were replaced with
mean values. Outliers were defined as any value that is either above or below 2 standard
deviations from the mean. There were two outlying data points for total distance traveled in
the Open Field Test. On PD 26, one rat from the NC-amphetamine group was identified as
an outlier and replaced with a group mean value for that date. On PD 27, one rat from the
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IC-water group was identified as an outlier and replaced with the group mean value for that
date. For time spent in the inner zone, there were five total outliers. One was from a NCamphetamine on PD 40, 1 from an IC-amphetamine on PD 26, 1 from an IC-amphetamine
on PD 41, and 1 from the ET-amphetamine on PD 40 and 41. Following statistically

significant main effects or interactions, Tukey’s HSD post hoc tests or simple effects tests
were run as appropriate.
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Treatment
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Figure 2.1. Timeline for Dose-Response Study.
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Figure 2.2. Open Field Test Apparatus.This Figure depicts the square, plexiglass
chamber used in the Open Field Test. Inner versus outer zones were measured
accordingly.
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Figure 2.3. Timeline for the FASD study.
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Perfused
30

35

40

OFT 4

Figure 2.4. Targets from coronal sections. The top target is the NAcc. The
bottom target is the medial PFC.
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A

B

Figure 2.5.A. DBH staining in medial prefrontal cortex. B. ImageJ
dichromatization of DBH staining. Analysis is expressed as total immunopositive
pixels.
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CHAPTER 3
RESULTS
3.1 DOSE-RESPONSE STUDY
This study examined the acute and chronic dose-response effects of therapeutic
doses of amphetamine treatment across the periadolescent developmental window.
3.1.1 BODY WEIGHTS
A repeated measures ANOVA revealed no interaction between day and drug
treatment, F(3, 14)=1.26, p > 0.05, nor was there a main effect of drug treatment on
body weight, F(3, 14) = 0.410, p > 0.05. Body weight was significantly impacted by day
which was expected across development, F(3, 14)=179.61, p < 0.05. As day increased, so
did body weight. This indicated that all animals grew appropriately, and amphetamine
treatment did not result in attrition which is a potential negative side effect with higher
doses of stimulants. These results are summarized in Table 3.1.
3.1.2 BEHAVIORAL MEASURES
A repeated-measures ANOVA demonstrated that total distance traveled
exhibited a main effect of day, F(1, 26)=38.34, a main effect of treatment, F(3,
26)=22.92, and a day*treatment interaction, F(3, 26)=4.85, p < 0.05. Tests for simple
effects revealed that on the first day of testing, rats given medium (1.0 mg/kg/day) and
high (2 mg/kg/day) doses of amphetamine moved significantly more than rats given
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water or a low (0.5 mg/kg/day) dose of amphetamine, p < 0.05. At the last day of
testing, all doses of amphetamine significantly increased locomotion over water, p <
0.05. This indicates that locomotor effects of amphetamine were sensitized over time.
However, there was no difference between rats given the medium and high doses of
amphetamine on the last day of testing, p > 0.05. In summary, the low dose of
amphetamine was not sufficient to induce a change in locomotion acutely, and there
was no difference between the medium and high dose. These data are summarized in
Figure 3.1.
Time spent in the inner zone demonstrated a main effect of treatment, F(3,
26)=5.44, p < 0.05. Post-hoc tests revealed that a medium or high dose of amphetamine
significantly increased time spent in the inner zone when compared to water treatment,
p < 0.05. In addition, while 1.0 mg/kg/day amphetamine significantly increased time
spent in the inner zone when compared to 0.5 mg/kg/day amphetamine, p < 0.05, mean
time spent in the inner zone decreased in the 2.0 mg/dg/day amphetamine group.
Therefore 2.0 mg/kg/day amphetamine was not significantly different from either the
0.5 mg/kg/day dose or the 1 mg/kg/day dose, p > 0.05. Anxious rats have a tendency to
remain close to the walls and explore the peripheral zone in an open field test, a
behavior termed thigmotaxis. Decreased thigmotaxis with the 1 mg/kg/day dose of
amphetamine can be indicative of decreased anxiety at this dose. There was also a main
effect of day, F(3, 26)=4.64, p < 0.05, but no day*treatment interaction, p > 0.05. Time
spent in the inner zone increased from acute (PD 26) to chronic (PD 40) time points,
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indicating an effect of age on exploratory behavior. These results are summarized in
Table 3.2.
The medium dose of amphetamine was selected for use in the FASD study for
two reasons: 1) this dose resulted in both the greatest acute effects as well as the
greatest sensitization of behavioral effects over time, and 2) the high dose of
amphetamine exhibited significantly higher measures on anxiety than the medium dose.
3.2 FASD STUDY
This study examined the effect of amphetamine treatment across the
periadolescent developmental window using a model of FASD. This study used the
medium dose of amphetamine, as determined by the results in the dose-response
study.
3.2.1 BECS & BODY WEIGHTS
BECs for ethanol-exposed animals were 418.8±87.4 (SEM). Body weight
significantly increased from PD 2 to PD 10, which is expected during development, F(8,
35) = 939.47, p < .05. Ethanol treatment did not significantly impact body weight in
neonatal rats, F(2, 27) = 0.41, p > 0.05. This indicates than any group differences with
ethanol treatment are not due to malnutrition. These data are summarized in Table 3.3.
There was no main effect of amphetamine on body weight, F(1, 35) = 0.04, p
>0.05. Neither was there an interaction between amphetamine and neonatal ethanol
exposure, F(2, 35) = 0.60, p > .05. This indicates that amphetamine did not induce
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weight loss in these groups, and ethanol treated rats were not more sensitive to weight
loss effects of amphetamine than controls. These data are also summarized in Table 3.3.
3.2.2 BEHAVIORAL MEASURES
Analyses of total distance traveled revealed two main effects and an interaction.
There was a main effect of day, F(3, 49) = 17.59, p < .05, and drug treatment, F(1, 51) =
95.87, p < 0.05. There was also a significant day*treatment interaction, F(3, 49) = 6.60, p
< 0.05. Analyses of simple main effects revealed that within the amphetamine
treatment group, total distance traveled significantly increased an average of
2096.19±475.79 cm from PD 26 to PD 27, p < 0.05, an average of 2890.82±504.75 cm
from PD 26 to PD 40, p < 0.05, an average of 3881.48±474.44 from PD 26 to PD 41, p <
0.05, an average of 1785.29±474.44 from PD 27 to PD 41, p < 0.05, and average of
990.66±331.70 cm from PD 40 to PD 41, p < 0.05. These data are represented as mean ±
SEM. Total distance traveled did not significantly increase across any days in the water
treatment groups. These results indicate that amphetamine induced hyperactivity
acutely and that rats became sensitized to the locomotor effects of amphetamine
chronically, irrespective of neonatal ethanol exposure condition. These results are
summarized in Figure 3.2.
Analyses of time spent in the inner zone revealed a main effect of day, F(3, 51) =
8.39, treatment, F(1, 53) = 41.22, and a day*treatment interaction, F(3, 51) = 12.75, p <
0.05. Analyses of simple main effects revealed that within the amphetamine treatment
condition, time spent in the inner zone increased an average of 31.41±7.23 seconds
from PD 26 to PD 27, p < 0.05, an average of 42.06±5.1 seconds from PD 26 to PD 40, p <
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0.05, and an average of 42.41±6.01 seconds from PD 26 to PD 41 p < 0.05. Time spent in
the inner zone did not change within water treatment groups. These data are
represented as mean ± SEM with results summarized in Figure 3.3.
Rearing behaviors were also analyzed as a measure of stereotypy. Rearing
behaviors exhibited a main effect of day, F(3, 37) = 6.04, p < 0.05, and treatment, F(1,
39) = 36.75, p < 0.05. Rearing behaviors decreased as day increased when collapsed
across all conditions (Figure 3.4). Specifically, rearing behaviors decreased from PD 26 to
PD 40 by an average of 18.71±7.67 counts. As expected, rats receiving amphetamine
treatment exhibited more rearing behaviors than rats receiving water treatment. These
data indicate that amphetamine did not differentially induce rearing by treatment
groups, suggesting that ethanol-exposed groups were not more sensitive to this form of
stereotypy.
Grooming exhibited main effects of day, F(3, 36) = 8.51, p < 0.05, and treatment,
F(1, 38) = 49.91, p < 0.05. Amphetamine significantly reduced grooming behavior from
an average of 92.70±5.61 seconds±SEM within water treated groups to 38.47±5.59
seconds±SEM. Grooming behavior also significantly decreased from acute (79.64±5.43)
to chronic (54.42±5.28) sessions, indicating a developmental impact on grooming
behavior.
3.2.3 IMMUNOHISTOCHEMISTRY
An omnibus ANOVA revealed no impact of ethanol exposure or amphetamine
treatment on DAT or TH, p > 0.05. Data are provided in Table 3.4.
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There was a significant effect of treatment on DBH staining within the prefrontal
cortex, F(1, 37) = 27.04, p < 0.05, but no effect on exposure, and no interaction. DBH was
significantly increased following amphetamine treatment. DBH results and
representative pictures of staining are displayed in Figure 3.5.
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Table 3.1
Change in Body weights (g) During Amphetamine Treatment

Dose-Response Study
Treatment
H2O
0.5 mg/kg/day AMPH
1 mg/kg/day AMPH
2 mg/kg/day AMPH

Change in Body Weight (g)
71.16±2.99
72.01±1.98
74.86±2.92
74.86±2.92
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Figure 3.1. Total Distance Traveled in Dose-Response Study. Data are
represented at both acute (PD 26, 27) and chronic (PD 40, 41) time points. Data
are expressed as the mean ± SEM. Amphetamine significantly increases total
distance traveled in a dose response fashion. Asterisks represent data that is
significantly different from the water treatment group, p < 0.05.
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Table 3.2.
Behavioral Data for the Dose-Response Study

Treatment

Distance Traveled (cm)

Time in Inner Zone (sec)

Acute

Acute

Chronic

Chronic

H2O

4332.± .474

4802.± .423

15.± .9

20.± .9

0.5 mg/kg/day AMPH

5855.± .658

8886.± .1105

24.± .7

54.± .20

1.0 mg/kg/day AMPH

7887.± .731

13571.± .1170

57.± .16

73.± .13

2.0 mg/kg/day AMPH

9336.± .544

12569.± .828

34.± .11

67.± .16
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Table 3.3.
Exposure and Treatment Impact on Body Weights (g)

Non-treated
Control
11.29±0.37

Intubated
Control
11.24±0.41

Ethanol
Treated
10.56±0.36

H2O

70.99±3.07

69.25±2.43

71.20±2.19

Amphetamine

66.48±2.76

67.22±1.47

67.44±2.45

PD 2-10
PD 26-40
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H2O NC
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26
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41

Figure 3.2. Total distance traveled (cm) in the Open Field Test for the FASD
Study. Acute testing consists of postnatal days 26 and 27. Chronic testing consists
of postnatal days 40 and 41. Habituated testing is the second test day during the
acute and chronic conditions. The data are expressed as the mean ± SEM.
Asterisks represent data significant from H2O, p < 0.05. Pound symbols represent
data significant from PD 26.
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#
#

Time Spent in Inner Zone (s)
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*
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*
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NC-AMPH
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1
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2
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3
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4
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Figure 3.3. Time in Inner Zone in FASD Study. Data represent time spent in
the inner zone at PD 26, 27, 40, and 41 respectively. Time was evaluated as
total seconds in inner zone. The data are expressed as the mean ± SEM.
Asterisks represent data significant from H2O, p < 0.05. Pound symbols
represent data significant from PD 26.
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Figure 3.4. Rearing in FASD Study. Counts of rearing are expressed across all
four Open Field Tests. Ethanol exposure groups have been collapsed. The data
are expressed as the mean ± SEM. Asterisks represent data significant from
H2O, p < 0.05. Asterisks represent data significant from H2O, p < 0.05. Pound
symbols represent data significant from PD 26.

64

Table 3.4.
Immunohistological Analysis via Optical Density

Tyrosine Hydroxylase
ET
IC
NC

H2O
2898.± .433
3092.± .371
3001.± .361

AMPH
3166.± .320
3325.± .247
3298.± .261
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Dopamine Transporter
H2O
3371.± .61
3859.± .189
3775.± .132

AMPH
3844.± .167
3943.± .159
4064.± .122

Immunopositive Pixelss

A.

DBH
250000

*

200000

*

*

IC

ET

150000

B.

NC
H2O
IC

NC

H2O

ET

AMPH

AMPH

0.17 mm

Figure 3.5. A. Immunopositive staining for DBH in the medial prefrontal cortex,
as analyzed by ImageJ. The data are expressed as the mean ± SEM. B.
Representative pictures of DBH staining by exposure group and treatment.
Images represent staining within layers II/III from the medial PFC.
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CHAPTER 4
DISCUSSION
The current studies support previous literature indicating that amphetamine
increases locomotor activity acutely (Dandiya & Kulkarni, 1974), and that this activity
becomes sensitized chronically (Lynch, Kennny, & Leonard, 1978). In the dose-response
study, amphetamine increased total distance traveled acutely, and these effects were
sensitized over time. Sensitization to amphetamine-induced locomotor hyperactivity
was replicated in the FASD study. However, contrary to hypotheses, ethanol-treated rats
did not exhibit any behavioral differences in the open field test, nor did they exhibit any
differential response to amphetamine. These behavioral findings are paralleled by
neurochemical data. DBH staining in the medial prefrontal cortex was increased in
amphetamine treated rats, but there were no differences DBH, DAT, or TH staining in
any neonatal treatment groups for the FASD paradigm.
4.1 DOSE-RESPONSE STUDY
The dose-response study examined the acute and chronic dose-response effect
of multiple therapeutic doses of amphetamine on locomotor behavior in female rats. In
accord with previous literature, amphetamine induced a dose-response increase in total
distance traveled (i.e. locomotor activity) when it is first administered on PD 26.
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Chronically (PD 40), amphetamine-induced locomotor hyperactivity increased
further, indicating sensitization. However, there were no significant differences between
the medium and high doses chronically, suggesting that 1 mg/kg/day of amphetamine is
sufficient to induced changes in locomotor behavior but that increasing that dose is not
necessary.
In addition to increasing locomotor behavior, amphetamine treatment impacted
time spent in the inner zone both after one administration and chronically. Unlike the
effect on locomotion, amphetamine did not exhibit a linear dose-response effect on
time spent in the inner zone. Rather, time spent in the inner zone increased with a
medium (1 mg/kg/day) but not a not high (2 mg/kg/day) or low dose of amphetamine
(0.5 mg/kg.day). Although crude, more time spent in the inner zone can be indicative of
an anxiolytic response as time spent in the inner zone tends to increase with anxiolytic
drugs (Prut & Belzung, 2003; Wallace et al., 2008). In contrast, wall hugging (i.e.
thigmotaxis) can be considered an anxiogenic behavior (Wallace et al., 2008). Time
spent in the inner zone may reflect evolutionary mechanisms modulating necessary risk
taking in new environments for exploration to find food and mates. Low anxiety and
high exploration in novel environments are also important during adolescence as these
behaviors are thought to help develop independence (Spear, 2000). The anxiogenic
response to higher doses of amphetamine is well-substantiated in the literature (Biala &
Kruk, 2007; Cancela et al., 2001; Pellow et al., 1985). In contrast, the anxiolytic response
of the medium dose of amphetamine is not well documented. These results could
indicate a curvilinear relationship between the pull of environmental exploration and
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risk-assessment responses from non-specific threats: moderate activation of
catecholamine networks enhance exploratory behavior but higher activation induces
anxiogenic responses (Prut & Belzung, 2003).
Importantly, time spent in the inner zone is not correlated with the distance
traveled: higher doses of amphetamine resulted in increased distance traveled but
decreased time spent in the inner zone compared to the medium dose.
Underdevelopment of the prefrontal-limbic circuits in juveniles may have contributed to
the medium dose’s interesting effect (Lewis, 1997). 1 mg/kg/day of amphetamine may
provide optimal activation within the prefrontal cortex without provoking an anxiogenic
response with over-activation at prefrontal glutamatergic inputs.
These results suggest two things: 1) a medium dose is sufficient to induce a
behavioral change in locomotion, and 2) increasing the dose beyond this point is
unnecessary. Collectively, the dose-response data supported the use of 1mg/kg/day of
amphetamine for the FASD study.
4.2 FASD STUDY
This study examined the impact of a third-trimester binge paradigm of ethanolexposure followed by chronic amphetamine administration on behavioral hyperactivity
and catecholamine networks. Although amphetamine induced several behavioral effects
and one neurochemical effect, ethanol-exposed animals were not differentially
impacted on any measures.
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4.2.2A BEHAVIORAL DATA
In the FASD study, amphetamine increased distance traveled in all groups. Like
the dose-response study, this effect on locomotion became sensitized over time. In
addition, amphetamine increased time spent in the inner zone acutely, and this effect
became sensitized chronically within the study. This is in agreement with the doseresponse study regarding data on the medium dose but not the high dose of
amphetamine, indicating that behavioral effects are dose-dependent.
Two additional behavioral measures were added in the FASD study: rearing and
grooming. Rearing behaviors were used as a marker of amphetamine-induced
stereotypy. Unsurprisingly, rats treated with 1 mg/kg/day amphetamine exhibited more
rearing behaviors than their water-treated counterparts. However, all rats
demonstrated decreased rearing across each testing day, and there was no interaction
between amphetamine and testing days on rearing behavior. One explanation is that at
this dose, amphetamine does not induce sensitization to stereotypy. Alternatively,
rearing behavior may have decreased over time due to progression to minute, oral
stereotypies. However, Scholl et al. (2009) demonstrated that even at 6 consecutive
intraperitoneal injections of 2.5 mg/kg amphetamine, intense oral stereotypies were
minimal. This suggests that the current dose did not result in sensitization of stereotypy,
which would have been a negative consequence for a chronic therapeutic dose.
Unlike rearing, grooming behavior was inversely related to amphetamine
treatment. Because grooming is sometimes taken as a measure of anxiety, this indicates
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that amphetamine increased exploratory behavior without increasing anxious behavior
(Dunn et al., 1987). This parallels that finding that amphetamine increased time spent in
the inner zone compared to controls. Collectively, these results argue that chronic
administration of 1 mg/kg/day dose of amphetamine does not have anxiogenic effects.
In contrast, Cancela et al. (2001) demonstrated that 2 mg/kg intraperitoneal injections
of amphetamine for 9 consecutive days did induce anxiogenic responses in an elevated
plus maze. Because the 2 mg/kg/day dose of amphetamine in the current dose-response
study increased distance traveled but decreased time spent in the inner zone when
compared to the 1 mg/kg/day dosage, the current study supports the proposal of a
threshold dose for anxiogenic effects of stimulants. Many studies utilize 2 mg/kg doses
of amphetamine as equivalent to a therapeutic dose used in humans. The current study
does not support these results. Rather, these data suggest that doses should not exceed
1 mg/kg/day in order to avoid negative behavioral and potentially neurological
consequences.
Contrary to the hypotheses that ethanol-treated rats would exhibit hyperactivity,
ethanol-treated rats did not exhibit increases in locomotion nor did they show
differential responses to amphetamine compared to control rats. Similarly, there were
no differences among groups with respect to time spent in the inner zone. Generally,
hyperactivity is the result of either insufficient inhibition of locomotion during
exploration or deficits in habituation to the environment (Riley, 1990). Associations with
locomotor hyperactivity have yielded mixed results in animal models. These results
appear to vary by three factors: age, exposure paradigm, and sex.
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In regards to age, young rats show enhanced hyperactivity compared to
adolescent and young-adult rats. An early study by Means et al. (1984) demonstrated
hyperactivity in male rats exposed to ethanol prenatally via a liquid diet paradigm at
postnatal day 26. Means et al. (1984) also demonstrated that ethanol-exposed rats were
hypersensitive to the locomotor-inducing effects of methylphenidate at 100+ days of
age. Kelly, Hulsether, and West (1987) demonstrated that hyperactivity peaks around
postnatal day 20 and declines by postnatal day 30. This hyperactivity re-emerges in aged
rats (Abel &Dintcheff, 1986). These studies suggest that locomotor activity in ethanolexposed rats exhibits a curvilinear function.
Although locomotor hyperactivity is not a direct measure of attention, the
relationship between locomotor hyperactivity and attention is extremely important in
FASD. Hyperactivity is frequently reported in children with FASD, although it is replaced
by attentional deficits during pre-adolescent development (Driscoll et al., 1990). This
developmental shift between hyperactivity and attention deficits in human studies
parallels the curvilinear function of hyperactivity demonstrated in animal models.
Therefore one possibility for the lack of hyperactivity in ethanol-exposed rats is that the
tested ages (PD 26, 27, 40, and 41) fell within the developmental depression of
hyperactivity demonstrated in animal models. Comparison with human studies suggests
that this depression in hyperactivity may be due to developmental shifts toward
attentional deficits. This possibility necessitates further studies examining attentional
capacities during this age range.
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Variation in locomotor activity by age was also reported by Marche, Danel, and
Bordet (2011). However, in contrast with previous studies, Marche, Danel, and Bordet
demonstrated decreased locomotion (i.e. hypoactivity) in rats exposed to ethanol
prenatally at three weeks (~postnatal day 21), increased locomotion (i.e. hyperactivity)
of those same rats at 5 weeks (~postnatal day 35), and then a return to hypoactivity at
10 weeks (~postnatal day 70). These effects contradict previous research. One major
difference between these studies is that Marche, Danel, and Bordet (2010) used a much
more extensive exposure paradigm. Dams were exposed to alcohol for four weeks
before breeding, throughout gestation, and then for 3 weeks during lactation. Because
the last period of exposure extended past the human equivalent of the third trimester
(Bayer et al., 1993), these data may not generalize to the human condition. However,
these data do suggest that the relationship of ethanol-exposure on activity can vary
substantially and potentially be inverted, depending on exposure paradigm.
The most compelling differences in activity are found in examining sex
differences. Most studies (Means et al., 1984; Marche, Danel, & Bordet, 2011)
exclusively examine males whereas the current study examined females. Wilcoxon et al.
(2005) demonstrated that locomotor activity varies by sex. Using a liquid diet paradigm
of alcohol exposure, Wilcoxon et al. (2005) demonstrated hypoactivity in females in an
open field test at postnatal day 100. This decrease in locomotor activity was not evident
in males. Similarly, Gilbertson and Barron (2005) documented hyperactivity following
neonatal ethanol exposure during postnatal days 19-21. However, hyperactivity during
this period was limited to males. Females were not significantly different from controls.
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Because males are more commonly used in animal research, the current study supports
the need to include females in future studies, especially in regards to the developmental
effects of ethanol.
In conclusion, hyperactivity is most frequently reported in males during
preadolescent (PD ~21) and adult (PD 100+) ages following prenatal exposure using
prenatal exposure and liquid diet paradigms. Because the current study used females
and a third-trimester exposure paradigm, and because activity was monitored between
PD 26 and 41, hyperactivity in exploratory behavior may not have been evident.
An alternative explanation for failure to demonstrate hyperactivity in ethanolexposed rats is that hyperactivity was masked by an augmented stress response. Animal
models of FASD are robustly associated with a hyper-reactive hypothalamic-pituitaryadrenal axis and behavioral responses to stress (Taylor et al., 1982; Weinberg, 1992;
Hellemans et al., 2010). This stress-response could also have been elicited due to
variations in testing conditions between studies. Rats habitually prefer dark or dim-light
settings (8-13 lux). Bouwknecht et al. (2007) demonstrated that high-light conditions
(400 lux) in an open field test significantly reduced locomotor activity and increased
anxiety responses when compared to low-light conditions, indicating that low-light
conditions reduce anxiety behaviors. Thomas et al. (1998) demonstrated hyperactivity in
rats neonatally exposed to alcohol, but testing was conducted in dark conditions.
Similarly, Wilcoxon et al. (2005) demonstrated age and sex effects of a liquid diet
paradigm of alcohol exposure, but testing conditions were performed at 160 lux. As the
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current experiment was tested at high-light settings (400 lux), sex and age may have
also impacted sensitivity to lighting-induced stress effects.
Weinberg (1992) demonstrated that the stress response, as indicated by
corticosterone reactivity, of ethanol-treated rats following four-hours of restraint stress
is greater in females than males. Since the current study used only females, lightinduced stress may have had a greater impact on locomotion than in previous
experiments. In sum, stress from lighting conditions in the current study could have
increased anxiogenic behavior which would result in decreased locomotion, masking
any hyperactivity in ethanol-treated rats.
The lack of developmental impact of ethanol on rearing behaviors in the current
study is discordant with previous studies. Using a liquid diet paradigm of ethanol
exposure, Wilcoxon et al. (2005) demonstrated that rearing behaviors are impacted by
ethanol exposure in a sex-dependent manner: females reared more than males, but
females exposed to ethanol reared less than controls. This finding was not replicated in
the current study. Females exposed to alcohol showed no differences in rearing when
compared to intubated and non-treated controls across any testing day. This could be
due to paradigm differences as the current study used a binge-drinking paradigm
whereas Wilcoxon et al. used a liquid-diet paradigm for FASD. Alternatively, differences
in ethanol’s impact on rearing behaviors could be due to age-differences. The current
study tested rats at PD 40 whereas Wilcoxon et al. performed the open field test at PD
100.The developmental impact of ethanol on rearing may only be noticeable in older
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rats. This hypothesis is supported by the study by Marche, Danel, & Bordet (2011).
Marche, Danel, & Bordet (2011) demonstrated that rearing behaviors decrease in an
age-dependent manner. At 3 weeks of age, ethanol-exposed rats exhibited similar
rearing behaviors to their controls. However, by 10 weeks of age, ethanol-exposed rats
reared less than controls. Because the current study only examined rats just over 5
weeks of age, ethanol’s impact on rearing may have been obscured by the juvenile drive
for exploration.
In conclusion, ethanol-treated rats did not exhibit any behavioral differences in
the open field test. Ethanol-treated rats also did not exhibit any differential response to
amphetamine. Although multiple studies have suggested that ethanol-treated rats
should exhibit hyperactivity, failure to replicate this finding could be due to 1) lighting
conditions in the open field environment, or 2) an attentional task would have been
more suitable measure considering the developmental age at which the open field tests
were conducted. The current study did support well established results in the field that
amphetamine induces locomotion in a dose-response fashion. Importantly, the current
study supports the idea that in order for animal studies to exhibit human translational
validity for therapeutic uses of amphetamine, dosages should not exceed 1 mg/kg/day.
This finding encourages re-evaluation of dosing procedures for future studies in these
fields.
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4.2.2B NEUROANATOMICAL DATA
Although amphetamine mechanistically impacts both dopaminergic and
noradrenergic neurons, only DBH staining in the prefrontal cortex was impacted by
amphetamine in the current studies. DBH staining increased in the medial prefrontal
cortex in rats chronically treated with amphetamine during the periadolescent window,
meaning that there was an increase in either noradrenergic innervation or synthesis.
Amphetamine did not impact DAT or TH, nor was there an effect of alcohol treatment
on any markers.
An increase in DBH may indicate an increase in innervation by noradrenergic
axons. Innervation may be due to either 1) amphetamine-induced plasticity of the
prefrontal cortex during the periadolescent developmental window, or 2)
amphetamine-induced plasticity that is independent of developmental period. Because
the adolescent prefrontal cortex is undergoing rapid maturation and reorganization of
neural networks, drug exposure during this time window can change developmental
trajectories (Andersen, 2004). The former hypothesis parallels a similar finding by
Reynolds et al. (2014) that chronic amphetamine treatment during adolescence (PD 2231) but not adulthood (PD 75-84) increases dopaminergic innervation in the medial
prefrontal cortex in mice. Conversely, this increase in innervation was paralleled by a
reduction of presynaptic sites on dopaminergic axons. Reynolds et al. (2014) suggest
that drug exposure during adolescence has an increased ability to alter neural networks.
Unlike the current study, Reynolds et al. (2014) examined dopaminergic and not
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noradrenergic networks. Reynolds et al. (2014) also used a much larger (4 mg/kg) dose
of amphetamine as a means of studying adolescent exposure to drugs of abuse.
However, the same principles apply to the current study: the adolescent window may
be sensitive to changes in noradrenergic innervation within the medial prefrontal cortex
following repeated amphetamine exposure.
Within the medial prefrontal cortex, noradrenergic networks may be more
sensitive to chronic amphetamine than dopaminergic networks. Berridge and Stalnaker
(2002) demonstrated that a 0.5 mg/kg subcutaneous injection of amphetamine
increased extracellular norepinephrine levels 175% above baseline and extracellular
dopamine levels by only 125% above baseline. Baseline concentrations of DA and NE
were both approximately at 1 pg/20 uL of cerebral spinal fluid. Amphetamine’s ability to
preferentially increase extracellular levels of NE in the medial prefrontal cortex may be
due to anatomical distinctions between DAT and the noradrenergic transporter (NET).
DAT has higher concentrations and clearance capacity within the infralimbic cortex
whereas NET has higher concentrations within the medial prefrontal cortex (Heidbreder
& Groenewegen, 2003). Because amphetamine reverses both DAT and NET to force
release of presynaptic NE and DA, amphetamine may have a greater impact on
noradrenergic levels due to increased NET concentration within this region.
The ability of a therapeutic dose of amphetamine to change developing
neurocircuitry could have significant behavioral and cognitive effects for adolescents
using stimulant medication. Within the prefrontal cortex, noradrenergic neurons act as
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neuromodulators of glutamatergic pyramidal afferents (Ji et al., 2008; Market &
Aghajanian, 1999; Steketee, 2003). Therefore, changes in noradrenergic innervation
could have significant impacts on afferent projects of other neurotransmitter systems.
This, in turn, could impact functions dependent upon the medial prefrontal cortex such
as arousal, attention, and working memory (Dalley, Cardinal, & Robbins, 2004).
In addition, noradrenergic release within the prefrontal cortex modulates
amphetamine-induced hyperactivity (Darracq et al., 1998). Darracq et al. (1998)
demonstrated that locally administering an α-1 noradrenergic antagonist into the rat
prefrontal cortex in conjunction with an intraperitoneal injection of 2.0 mg/kg
amphetamine blocked amphetamine-induced locomotor hyperactivity without
impacting amphetamine induced dopamine release in the nucleus accumbens. This
suggests that stimulation of noradrenergic postsynaptic receptors are critical for
amphetamine’s effect on locomotion. Changes in noradrenergic innervation within the
prefrontal cortex may partially explain sensitization to locomotion following chronic
amphetamine administration. This would also explain sensitization to amphetamineinduced locomotion following chronic treatment in the absence of changes in TH or DAT
content in the current study.
Contrary to predictions, neither dopaminergic nor noradrenergic markers varied
by alcohol exposure. One possibility is that synthesis markers like TH and DBH may be
resistant to neonatal ethanol exposure. Alternatively, physiological changes in these
systems may not be reflected in immunohistological measures. The latter is supported
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by electrophysiological studies by Shen, Hannigan, & Kapatos (1999). Shen et al. (1999)
demonstrated that mesolimbic dopaminergic neurons had reductions in spontaneous
firing patterns. However, there were no differences in tyrosine-hydroxylase based cell
counts. Because the current study also examined TH staining, dopaminergic neurons
may have exhibited electrophysiological alterations that were not detectable with the
current methods.
Although dopamine-beta hydroxylase specifically has not been investigated
previously, literature regarding noradrenergic content has yielded mixed results.
Although some of these differences can be explained by variations in alcohol exposure
paradigms, Rudeen & Weinberg (1993) suggested that even when no baseline
differences in noradrenergic content are detected, deficiencies in noradrenergic systems
become evident following stressors. Therefore one explanation of the current data is
that immunohistological measures did not capture functional differences in ethanolmediated effects on noradrenergic neurons. This explanation would be in accord with
previous studies regarding dopamine which suggests that synthesis enzymes may not be
good markers for ethanol’s developmental impact on catecholaminergic networks.
In summary, chronic amphetamine increased noradrenergic innervation within
the prefrontal cortex, but not dopaminergic markers within the nucleus accumbens. This
increase in innervation could partially explain sensitization to amphetamine-induced
locomotor hyperactivity. Ethanol did not impact any neurological measures. This may be
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due to functional rather than structural differences in catecholaminergic transmitter
systems.
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CHAPTER 5
FUTURE DIRECTIONS
The current study had many limitations which may have impacted results. These
limitations pertain to both behavioral measures as well as immunohistological
measures.
5.1 LIMITATIONS OF BEHAVIORAL MEASURES
The greatest limitation of the current study is that attention was not directly
measured. Rather, hyperactivity was used as a correlation of attentional indexes.
Human studies have suggested that hyperactivity diminishes during the ages tested in
this study in favor of attentional deficits (Driscoll et al., 1990). Hence, assessing
attention directly using a five choice-serial reaction test could provide a more sensitive
measure of cognitive deficits than the open field test (Robbins, 2002).
Although the open field test has been used as a measure of locomotor activity
for decades, examining locomotion in the open field test has many limitations and
confounding variables (Walsh & Cummins, 1976). Testing conditions, age, sex,
habituation to the testing chamber, and transport to the testing chamber all impact
locomotion (Walsh & Cummins, 1976). Because the current study used high-lighting
conditions, interactions with light-induced stress response and ambulation may have
confounded ethanol effects. Lighting conditions in an open field test could be lowered
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for future studies, which would hopefully decrease the anxiogenic response to the test.
Alternatively, using an elevated plus maze in conjunction to an open field chamber
would help separate anxiolytic behavior from locomotor behavior (Pellow et al., 1985).
Anxious rats spend more time in the closed arms of an elevated plus maze (Hogg, 1996).
Variations in time spent in the closed arms could then be used as a covariate for
locomotor activity, thus separating decreased activity due to anxiety from any
locomotor hyperactivity evident in the open field.
An additional limitation of the current study is that both experiments focused on
effects of alcohol and amphetamine in female rats. Due to the sex differences in
locomotor activity, development, vulnerability to ethanol-mediated damage, and
dopaminergic tone, examination of sex differences is an important future measure.
Success of pharmacological intervention for hyperactivity and attentional deficits may
be sex-dependent. Therefore, a future direction would be to investigate males and
females using the proposed measures.
A final behavioral point would be to investigate whether the potentially
beneficial effects of chronic amphetamine treatment in hyperactivity and attention
translate into the social realm in animal models. Deficits in social functioning are a core
feature of FASD children and provide far-extending repercussions due to the social
nature of educational development (Thomas et al., 1998). Non-FASD ADHD children that
have been treated with stimulants show a variety of benefits, including improved social
skills (Greene et al., 1999). Future studies could examine the impact of early chronic
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exposure to amphetamine followed by observations of social play. Activity in both the
striatum and medial prefrontal cortex are integral to the mediation of social play (van
Kerkhof et al., 2013). Because chronic amphetamine increased noradrenergic
innervation within the medial prefrontal cortex, these changes could also impact social
play behavior.
In sum, more elaborate behavior studies on attentional measures will be useful
future directions to rectify limitations in the current study. Future studies should include
both males and females as the current study suggests supports previous literature
suggesting that females exhibit different behaviors following developmental exposure
to alcohol than males.
5.1 LIMITATIONS OF NEUROLOGICAL MEASURES
Although DBH, DAT, and TH are integral to understanding the chronic effects of
amphetamine treatment for models of fetal alcohol syndrome, they are only the
preliminary steps in investigating the dopaminergic and noradrenergic systems with
regards to influence their influence on attention and hyperactive behavior in FASD. This
study was selective in examining the dopaminergic markers within the nucleus
accumbens and noradrenergic markers within the medial prefrontal cortex. In the
future, dopaminergic and noradrenergic markers should be examined within the same
brain region to provide a more cohesive picture of network integration. Markers for
acetylcholine would provide additional support on neural networks for attention as
acetylcholine is also robustly associated with modulation of attention networks. Post-
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synaptic receptors for dopamine, norepinephrine, and acetylcholine may also provide
insight as to how enhanced dopaminergic release impacts post-synaptic structure.
Examination of these postsynaptic markers within the prefrontal cortex is the next step
in this project.
Future studies should also assess phosphorylated TH and DBH to examine
activation of this enzyme rather than quantification of TH and DBH presence in general.
This presents a general limitation of all of these immunohistological measures: they do
not represent functional differences, only structural differences. An additional potential
future step would be to examine DAT, TH and DBH activity using functional assays. A
microdialysis study would also enable examination of real-time tonic and phasic
dopaminergic release providing indications of total neuronal load using a high K+ flush
and then recovery. This could provide more direct correlations between
neurotransmitter content and synthesis enzymes.
In conjunction to examining different areas in attention circuits, tissue from this
study should be examined in relation to glutamatergic morphology. Glutamatergic
neurons project from the nucleus accumbens to the prefrontal cortex, and
dopaminergic and noradrenergic modulation of these projections also may underlie
differences in attention. By integrating immunohistochemistry between these measures
as a multivariate analysis, neural networks of attention may be examined at a holistic
level.
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Also, although d-amphetamine is a classic stimulant drug used in ADHD
treatment, novel pharmacotherapies for ADHD involve non-stimulant drugs.
Atomoxetine holds particular promise as it is designed to target inattentive features of
ADHD – a symptom particularly prevalent in FASD populations. Atomoxetine targets
norepinephrine. Because noradrenergic networks demonstrated the greatest plasticity
in the current study, drugs targeting this system may have the greatest impact on
neurodevelopment within the prefrontal cortex during the periadolescent
developmental window.
This study aimed to provide further evidence towards dopaminergic and
noradrenergic impairments and the mechanisms behind common pharmacological
treatments in FASD. Thus far, amphetamine appears to have a selective impact on DBH
within the prefrontal cortex. However, examining interactions between different
neurotransmitter systems could provide a better explanation of networks influencing
attention and hyperactivity. Understanding the etiology behind FASD and its
relationship with symptomology and treatment will help guide future therapeutic
directions for this extremely prevalent and detrimental syndrome.
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